+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Public health impact of human papillomavirus vaccination on prevention of cervical cancer in France



Public health impact of human papillomavirus vaccination on prevention of cervical cancer in France



International Journal of Public Health 57(1): 149-158



To evaluate the cervical cancer (CC) reduction at individual and population level following different prevention strategies (age-specific vaccination and/or screening) in France. A lifetime Markov model was constructed with 11 health states covering the progression from human papillomavirus (HPV) infection to the development of precancerous lesions, CC and death. A screening module took into account the effects of detection and early treatment. Cohorts of girls were entered into the model at age 11 years; the model was run for 95 years using one-year cycles. Vaccination combined with screening substantially reduced the incidence of precancerous lesions and CC compared with screening alone. Vaccination was beneficial regardless of age at vaccination, but the greatest benefit was obtained with an early vaccination. The clinical results were the best for vaccination at 11-13 years when lifetime horizon was considered, and for vaccination at 15-17 years for shorter observation period. The model results indicate that HPV vaccination offers additional protection against CC when combined with screening. The optimum starting age for vaccination varies depending on the observation period duration.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036136316

Download citation: RISBibTeXText

PMID: 21710187

DOI: 10.1007/s00038-011-0273-5


Related references

SP3-28 Is vaccination against the human papillomavirus for prevention of the cervix uteri cancer indicated in Pakistan where there is no Pap smear cervical cancer screening program-a public health perspective?. Journal of Epidemiology & Community Health 65(Suppl 1): A416-A416, 2011

The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecologic Oncology 114(2): 360-364, 2009

Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination. Ghana Medical Journal 52(2): 94-102, 2019

Anticipating the Impact of Human Papillomavirus Vaccination on US Cervical Cancer Prevention Strategies. Journal of Lower Genital Tract Disease 22(2): 123-125, 2018

Human papillomavirus and public health: cervical cancer prevention. Ciencia and Saude Coletiva 15 Suppl 1: 1055-1060, 2010

Vaccination against human papillomavirus for prevention of cervix uteri cancer in Pakistan--a public health perspective and debate. Journal of Ayub Medical College, Abbottabad 23(2): 186, 2014

The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation 87(7): 1078-1091, 2009

Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer. Nederlands Tijdschrift Voor Geneeskunde 152(17): 981-983, 2008

Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru. Revista Panamericana de Salud Publica 32(6): 426-434, 2014

Vaccination against human papillomavirus for the prevention of cervical cancer. Nederlands Tijdschrift Voor Geneeskunde 150(25): 1380-1384, 2006

Human papillomavirus vaccination for prevention of cervical cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1594-1598, 2011

Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review. Current Opinion in Oncology 26(1): 120-129, 2014

Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Best Practice and Research. Clinical Obstetrics and Gynaecology 19(4): 531-544, 2005

Prospects for cervical cancer prevention by human papillomavirus vaccination. Cancer Research 66(21): 10229-10232, 2006

Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?. American Journal of Obstetrics and Gynecology 214(4): 490-493, 2016